| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910678024003321 |
|
|
Autore |
Waksman Ron |
|
|
Titolo |
Transcatheter mitral valve therapies / / Ron Waksman, Toby Rogers |
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Hoboken, New Jersey : , : John Wiley & Sons, Inc., , [2021] |
|
©2021 |
|
|
|
|
|
|
|
|
|
ISBN |
|
1-119-76374-6 |
1-119-49065-0 |
1-119-49067-7 |
|
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (403 pages) |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Nota di contenuto |
|
Cover -- Title Page -- Copyright Page -- Contents -- List of Contributors -- Introduction-The Mitral Book -- Chapter 1 The Pathology of Mitral Valve Disease -- 1.1 Introduction -- 1.2 General Anatomy of the Mitral Valve -- 1.2.1 Mitral Annulus -- 1.2.2 Leaflets -- 1.2.3 Chordae Tendineae and Papillary Muscles -- 1.2.4 Papillary Muscles and Left Ventricle -- 1.3 Pathology of Mitral Valve -- 1.3.1 Mitral Valve Stenosis -- 1.3.2 Aging Changes and Mitral Annulus Calcification (MAC) -- 1.3.3 Acute Mitral Regurgitation -- 1.3.4 Chronic Mitral Regurgitation -- 1.3.5 Degenerative MR -- Myxomatous Degeneration of the Mitral Valve -- 1.3.6 Functional MR -- References -- Chapter 2 The Importance of Minimally Invasive Approaches for Mitral Valve Repair -- 2.1 Introduction to Minimally Invasive Mitral Valve Surgery -- 2.2 The Importance of MICS MVS -- 2.3 Patient Selection -- 2.4 Surgical Setup-Fibrillating Heart MVS -- 2.5 Alternatives for Cannulation -- 2.6 Alternatives to Myocardial Protection -- 2.7 Mitral Valve Repair -- 2.8 Outcomes -- 2.9 Initiating Minimally Invasive Mitral Valve Repair Program -- 2.10 Conclusion -- References -- Chapter 3 When to Intervene-Should Surgical Guidelines Apply to Transcatheter Techniques in Treating Mitral Regurgitation? -- 3.1 Introduction -- 3.2 Primary MR -- 3.2.1 Current Guideline Recommendations -- 3.2.2 Transcatheter Therapies-New Guideline |
|
|
|
|
|
|
|
|
|
Applications? -- 3.3 Secondary MR -- 3.3.1 Current Guideline Recommendations -- 3.4 Conclusions -- References -- Chapter 4 Transcatheter Mitral Valve Therapies: A Three-Dimensional Echocardiographic View -- 4.1 Introduction -- 4.1.1 Mitral Valve Anatomy -- 4.1.2 Mitral Valve Structure and Function -- 4.1.3 Mitral Regurgitation Severity -- 4.1.4 Diagnosis of MR Severity: Proximal Isovelocity Surface Area Method -- 4.1.5 Diagnosis of MR Severity: Vena Contracta Method. |
4.1.6 Primary and Secondary MR -- 4.1.7 Mitral Regurgitation and Cardiovascular Death and Morbidity -- 4.1.8 Screening for MitraClip Suitability -- 4.1.9 MitraClip Procedure Guidance -- 4.1.10 Transseptal Puncture -- 4.1.11 MitraClip Delivery Guidance -- 4.1.12 Adequacy of MitraClip Implantation Assessment -- 4.1.13 Other Technologies -- 4.2 Conclusions -- References -- Chapter 5 CMR Assessment of Mitral Regurgitation -- 5.1 Introduction -- 5.2 Pulse Sequences Used in CMR -- 5.2.1 Cine Imaging -- 5.2.2 Phase Contrast Imaging -- 5.3 Assessment of MR Severity -- 5.3.1 Qualitative Assessment -- 5.3.2 Quantitative Assessment -- 5.3.3 Technical Considerations for the Quantitative Assessment of MR by CMR -- 5.4 Identification of MR Etiology -- 5.4.1 Primary MR -- 5.4.2 Secondary MR -- 5.5 The Role of CMR Assessment of MR in Clinical Practice -- 5.6 Conclusions -- References -- Chapter 6 CT Planning for TMVR and Predicting LVOT Obstruction -- 6.1 Introduction -- 6.2 History of Imaging for Mitral Valve Disease -- 6.2.1 TAVR CT Planning -- 6.2.2 Surgical and Transcatheter Mitral Interventions -- 6.3 Concept of Aortic and Mitral Valve Technology Development -- 6.4 Basics of CT Imaging Acquisition -- 6.5 Definition of Mitral Valve and TMVR device Landing Zone -- 6.6 Definition of LVOT -- 6.7 CT Methods for Neo-LVOT prediction modeling -- 6.8 CT Validation of Neo-LVOT Prediction Modeling Post-TMVR -- 6.9 Correlation Between Pre- and Post-TMVR CT Neo-LVOT Prediction Modeling -- 6.10 What Else Has CT Planning for TMVR Taught Us? -- Acknowledgments -- References -- Chapter 7 General Principles and State-of-the-Art Echocardiographic Evaluation of the Mitral Valve -- 7.1 Introduction -- 7.2 Mechanism and Etiology of Chronic MR -- 7.2.1 Transthoracic Echocardiography -- 7.2.2.1 Color Flow Doppler -- 7.2.2 Qualitative Assessment -- 7.2.2.1 Color Flow Doppler. |
7.3 Continuous Wave (CW) Density Jet -- 7.3.1 Semi-Quantitative Assessment -- 7.3.1.1 VC Width -- 7.4 Pulmonary Vein Flow/Mitral Inflow -- 7.4.1 Quantitative Assessment -- 7.5 Selection of Best Candidates for Interventions of the Mitral Valve -- 7.5.1 Echocardiographic Criteria of COAPT (Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients with Functional Mitral Regurgitation) Trial -- References -- Chapter 8 Intraprocedural Echocardiography for MitraClip -- 8.1 Introduction -- 8.2 Pre-Procedure Evaluation -- 8.3 Importance of the Baseline Study - TEE -- 8.4 The Transseptal Puncture -- 8.5 Guiding MitraClip System to Mitral Valve -- 8.6 Intraprocedural Guidance of Clip within Mitral Valve and Leaflets -- 8.7 Post-Clip-Deployment Assessment of Mitral Valve Function -- 8.8 Assessment of Complications and Iatrogenic ASD -- References -- Chapter 9 Intraprocedural Echocardiography for Transcatheter Mitral Valve Replacement -- 9.1 Introduction -- 9.2 Baseline Mitral Valve Assessment -- 9.3 Access to the Left Atrium, Left Ventricle, and Mitral Valve -- 9.4 Predeployment and Deployment Monitoring -- 9.5 Postdeployment Evaluation -- References -- Chapter 10 Transcatheter Repair: MitraClip for Degenerative Mitral Regurgitation -- 10.1 Surgery for Degenerative Mitral Regurgitation -- 10.2 Evidence Base for |
|
|
|
|
|
|
|
MitraClip -- 10.3 Challenges for the MitraClip Procedure -- 10.4 Evaluation of MitraClip for Less than Prohibitive-Risk DMR Patients -- 10.5 Future Directions for MitraClip and Alternative Approaches for Leaflet Repair -- 10.6 Summary -- References -- Chapter 11 MitraClip™ for Secondary Mitral Regurgitation -- 11.1 Introduction -- 11.2 European and US Clinical Practice Guidelines -- 11.3 The MitraClip System -- 11.4 MitraClip Preprocedural Planning -- 11.5 Surgical Outcomes Data. |
11.6 The COAPT and MITRA-FR Trials -- 11.7 Summary and Conclusions -- References -- Chapter 12 The Edwards PASCAL Transcatheter Valve Repair System -- 12.1 Introduction -- 12.2 The Edwards PASCAL™ Transcatheter Valve Repair System -- 12.3 Implantation Procedure -- 12.4 Compassionate-Use and Early Feasibility Data -- 12.5 Future Developments -- References -- Chapter 13 The Development of a Novel Percutaneous Treatment for Secondary Mitral Regurgitation-The Carillon® Mitral Contour System® -- 13.1 Introduction -- 13.2 REDUCE-FMR -- 13.3 The CARILLON Trial -- 13.4 Summary -- References -- Chapter 14 A Fully Percutaneous Mitral Ring: The Cardioband System -- 14.1 Introduction -- 14.2 Mitral Annulus Anatomy -- 14.3 Pathophysiological Role of the Mitral Annulus in Mitral Regurgitation -- 14.3.1 Mitral Annulus in FMR -- 14.3.2 Mitral Annulus in DMR -- 14.4 Surgical Annuloplasty in Mitral Regurgitation -- 14.5 The Cardioband System: Description of the Device -- 14.6 Procedural Planning -- 14.7 Clinical Studies -- 14.8 Possible Complications Related to the Implantation of Cardioband -- 14.9 Recurrence of Mitral Regurgitation Following Cardioband Implantation -- 14.10 Cardioband in Combination with Other Devices -- 14.11 Conclusions -- References -- Chapter 15 Transcatheter Mitral Cerclage Annuloplasty -- 15.1 Introduction -- 15.2 Cerclage Anatomy and Function -- 15.3 Limitations of Coronary Sinus Annuloplasty -- 15.4 Cerclage Annuloplasty Device -- 15.5 The Cerclage Procedure -- 15.6 Preclinical Experiments -- 15.7 Initial Human Experience -- 15.8 Future Directions -- 15.9 Summary -- Competing Interests -- References -- Chapter 16 The Transapical Off-Pump Mitral Valve Repair with the NeoChord Implantation (TOP-MINI) -- 16.1 Introduction -- 16.2 Technology -- 16.3 Patient Selection -- 16.4 Procedure -- 16.5 Echocardiographic Guidance -- 16.6 Examples. |
16.6.1 Ideal Anatomy -- 16.6.2 Acceptable Anatomy -- 16.6.3 Challenging Anatomy -- 16.6.4 Data -- 16.7 Conclusion -- References -- Chapter 17 AltaValve™-A Transcatheter Mitral Valve Regurgitation Treatment Technology -- 17.1 Clinical Need -- 17.2 Device Description -- 17.2.1 Principle of Operation -- 17.2.2 Device Construction -- 17.2.2.1 Stent -- 17.2.2.2 Stent Cap -- 17.2.2.3 Tissue Valve -- 17.2.2.4 Fabric Skirts and Sutures -- 17.2.3 Delivery Systems -- 17.3 Anatomical Imaging and Sizing -- 17.4 Preclinical and Clinical Experience -- 17.4.1 Animal Studies -- 17.5 Human Clinical Experience -- 17.6 Summary -- References -- Chapter 18 The ARTO Transcatheter Mitral Valve Repair System -- 18.1 Device Description -- 18.2 Procedural Details -- 18.3 Clinical Experience with the ARTO System -- 18.4 Unique Features of the ARTO System -- References -- Chapter 19 Transcatheter Mitral Annuloplasty: The Millipede Device -- 19.1 Background -- 19.2 The Millipede Device -- 19.3 Millipede Implantation Procedure -- 19.4 Surgical Millipede Implants -- 19.5 Millipede Clinical Results -- 19.6 Clinical Implications -- 19.7 Summary -- Author Disclosures -- References -- Chapter 20 Transapical and Transseptal Access for Transcatheter Mitral Valve Replacement: Techniques and Devices -- 20.1 Introduction -- 20.2 Transapical Approach -- 20.2.1 Technique -- 20.2.2 Devices in Active Clinical Trial |
|
|
|
|
|
|
|
|
|
Phase -- 20.2.2.1 Tendyne -- 20.2.2.2 Intrepid -- 20.2.2.3 CardiAQ -- 20.2.2.4 TIARA -- 20.2.2.5 HighLife -- 20.3 Transseptal Approach -- 20.3.1 Technique -- 20.3.2 Devices in Active Clinical Trial Phase -- 20.3.2.1 Sapien M3 -- 20.3.2.2 EVOQUE -- 20.3.2.3 Caisson -- 20.4 Conclusions -- References -- Chapter 21 Mitral Valve-in-Valve and Valve-in-Ring Therapies -- 21.1 Overview -- 21.2 Evidence -- 21.3 Procedure Planning -- 21.4 Procedure. |
21.5 Pitfalls and Solutions-POULEZ and LAMPOON. |
|
|
|
|
|
|
Sommario/riassunto |
|
"The mitral valve, also known as the bicuspid or atrioventricular valve, plays a major role in controlling the transfer of blood from the left atrium to the left ventricle. There are two main types of mitral valve disease that can lead to mitral regurgitation: degenerative, in which the leaflets or the sub-valvular apparatus are deformed, and functional, in which cardiomyopathic dilatation of the ventricle or atrium results in malcoaptation of otherwise structurally normal leaflets. In reality, mitral regurgitation is often caused by a combination of both degenerative and functional processes"-- |
|
|
|
|
|
|
|
| |